Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT03482219 · ClinicalTrials.gov registry record · NA
Rehabilitation for Arm Coordination and Hand Movement in Systemic Sclerosis
A NA study of Systemic Sclerosis and SSc, sponsored by University of Michigan.
- Completed
- Registry status
- NA
- Development phase
- 32
- Enrollment target
- 1
- Study location
NCT03482219: Completed NA study of Systemic Sclerosis and SSc, sponsored by University of Michigan.
NCT03482219 is a NA study of Systemic Sclerosis and SSc that has completed, run by University of Michigan. The registered enrollment target is 32 participants, below the 278-participant average among 26 other Systemic Sclerosis trials with a reported enrollment target (88% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT03482219, a NA study of Systemic Sclerosis and SSc, has completed, sponsored by University of Michigan.
- COMPLETED
- Registry status
- NA
- Development phase
- 32 participants
- Enrollment target
- 1
- Study location
Study Summary
The purpose of this study is to test two rehabilitation programs to improve arm function for patients with scleroderma. This is a Phase 2 randomized controlled trial in which participants will be assessed at baseline, 8 weeks, and 18 weeks. Participants will be randomized into an intensive intervention (8 individual sessions of occupational therapy plus a home exercise app) versus a home app treatment alone. The results of this study will be used to design a large multi-site trial in which optimized rehabilitation strategies can be used to help patients improve their arm function.
Primary Outcome
self-report questionnaire of physical function and symptoms. This is an 11-item questionnaire in which difficulty in several tasks involving the upper extremity are rated as well as interference and severity of symptoms. Items are averaged and converted to a 0 - 100 scale; a higher score indicates worse function.
Conditions Studied
Interventions
- OTHER Occupational therapy
- OTHER Home app intervention
Study Locations (1)
Michigan
- University of Michigan - Ann Arbor
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 32 participants |
| Start Date | 2018-04-16 |
| Est. Completion | 2020-09-26 |
| Phase | NA |
What the finished NCT03482219 record still lists
NCT03482219 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 32 participants, a relatively small participant target, below the 278-participant average among 26 other Systemic Sclerosis trials with a reported enrollment target (88% lower).
The record links to 2 conditions, with Systemic Sclerosis appearing as the primary indexed condition, and to 2 interventions - of which Occupational therapy is the first listed.
NCT03482219 reports a single indexed study location in Michigan.
Frequently Asked Questions
What is clinical trial NCT03482219 about?
NCT03482219 is a clinical study titled "Rehabilitation for Arm Coordination and Hand Movement in Systemic Sclerosis". The purpose of this study is to test two rehabilitation programs to improve arm function for patients with scleroderma. This is a Phase 2 randomized controlled trial in which participants will be assessed at baseline, 8 weeks, and 18 weeks. Participants will be randomized into an intensive intervent...
What is the current status of trial NCT03482219?
This trial is currently completed. It is a NA study. The enrollment target is 32 participants. The study started on 2018-04-16. Estimated completion is 2020-09-26.
What conditions does trial NCT03482219 study?
This clinical trial studies the following conditions: Systemic Sclerosis, SSc.
What interventions are being tested in trial NCT03482219?
The interventions under investigation include: Occupational therapy (OTHER), Home app intervention (OTHER).
Who is sponsoring clinical trial NCT03482219?
This trial is sponsored by University of Michigan, which has 1,327 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT03482219 being conducted?
This trial has 1 study location across Michigan. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Systemic Sclerosis
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT03482219's enrollment target sits among peer trials
32 16th of 26 higher than 10 of 26 other Systemic Sclerosis trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Systemic Sclerosis trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
-
Interrogating the Pathophysiological Mechanisms of Constipation in Patients With Systemic Sclerosis
RECRUITING · NA
-
Rheumatology-based Adaptive Intervention for Social Determinants and Health Equity
ACTIVE NOT RECRUITING · NA
-
Autologous Stem Cell Transplantation in Patients With Systemic Sclerosis
RECRUITING · Phase 2
-
A Safety and Efficacy Study Evaluating CTX112 in Adult Subjects With Refractory Autoimmune Disease
RECRUITING · Phase 1
-
A Study of AZD0120 in Autoimmune Diseases
RECRUITING · Phase 1
-
RESET-SSc: An Open-Label Study to Evaluate the Safety and Efficacy of CABA-201, a CD19-CAR T Cell Therapy, in Subjects With Systemic Sclerosis
RECRUITING · Phase 1
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT02445781 · 32 participants · Early Phase 1
Differing Levels of Hypoglycemia
- NCT02792270 · 32 participants · NA
Caloric Restriction In Sarcoma Patients Treated With Pre-Operative RT
- NCT03068910 · 32 participants · Early Phase 1
Hyperandrogenemia and Altered Day-night LH Pulse Patterns
- NCT03208868 · 32 participants · NA
Leucine Enriched Essential Amino Acid Mixture to Reverse Muscle Loss in Cirrhosis
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI